CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Neuroprogressive nature of sigma-1 receptor (Sig-1R) pathophysiology in unmedicated patients with acute major depressive disorder as investigated by (-)-F-18-Fluspidine PET
DOI 10.1055/s-0039-1683517
Bibliografische Angaben
Nachweis in CareLit
Autor:innenPM Meyer, M Strauß, GA Becker, S Hesse, K Bednasch, B Ettrich, S Wilke, F Zientek, M Rullmann, J Luthardt, S Fischer, M Patt, B Wünsch, P Brust, O Sabri
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2019
Jahrgang / SeitenJg. 58
Kernaussage aus der Literatur
Abstract-Vorschau
Neuroprogressive nature of sigma-1 receptor (Sig-1R) pathophysiology in unmedicated patients with acute major depressive disorder as investigated by (-)-F-18-Fluspidine PET
Zitieren
Zitierempfehlung
PM Meyer, M Strauß, GA Becker, S Hesse, K Bednasch, B Ettrich, S Wilke, F Zientek, M Rullmann, J Luthardt, S Fischer, M Patt, B Wünsch, P Brust, O Sabri (2019) Neuroprogressive nature of sigma-1 receptor (Sig-1R) pathophysiology in unmedicated patients with acute major depressive disorder as investigated by (-)-F-18-Fluspidine PET. Nuklearmedizin - NuclearMedicine, 58 (02). https://doi.org/10.1055/s-0039-1683517
Mit CareLit weiterarbeiten